Joint meeting with Hepatobiliary Cancers: Pathobiology and Translational Advances
Fatty Liver Disease and Multi-System Complications
March 22-24, 2021 | 10:00AM EDT | 2:00PM UTC | 3:00PM CET*
*Program is in development and subject to change
Joint Meetings
Your registration provides you with access to both the “Fatty Liver Disease and Multi-System Complications” and “Hepatobiliary Cancers: Pathobiology and Translational Advances” eSymposia events. Use the link below to explore the joint meeting features, including live plenary sessions, On Demand talks, posters, forums, job postings, 1:1 Connect appointments and more. This joint meeting access is designed to facilitate cross-disciplinary insights and collaborations to drive both fields in exciting new directions!
Preferred
(EDT)
Happening
Any Time
Content
Dates
Tracks
Speakers
Rooms
Showing results 1 - 9 of 9
Monday, March 22, 2021
[Joint Session] Welcoming Remarks and Keynote Session
10:00 AM - 11:10 AM EDT
Monday, March 22, 2021Room: Multi Tech Session Co-Chairs
Jay Horton, MD
University of Texas Southwestern Medical Center
Alphonse Sirica, PhD
Virginia Commonwealth University
[Joint Session] Welcoming Remarks and Keynote Session
[NOT AVAILABLE ON DEMAND] PNPLA3's Role in NAFLD
10:00 AM - 10:35 AM EDT
Monday, March 22, 2021Room: V100 Atticus Kiser Speaker
Helen Hobbs, MD
University of Texas Southwestern Medical Center
[Joint Session] Welcoming Remarks and Keynote Session
Changing Epidemiological Trends in Non-Alcoholic Fatty Liver Disease versus Viral-Associated Hepatobiliary Cancers
10:35 AM - 11:10 AM EDT
Monday, March 22, 2021Room: V100 Atticus Kiser Speaker
Hashem El-Serag, MD
Baylor College of Medicine
[Joint Session] Welcoming Remarks and Keynote Session
[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
11:10 AM - 1:00 PM EDT
Monday, March 22, 2021Room: Multi Tech Session Co-Chairs
Jay Horton, MD
University of Texas Southwestern Medical Center
Alphonse Sirica, PhD
Virginia Commonwealth University
[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
A TGF-ß-ALDH2 Axis in Obesity, Metabolic Syndrome, and HCC
11:10 AM - 11:35 AM EDT
Monday, March 22, 2021Room: V300 Guy Coombes Speaker
Lopa Mishra, MD
George Washington University
[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
Coffee Break
11:35 AM - 11:55 AM EDT
Monday, March 22, 2021[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
The Gut-Liver Axis in Liver Cancer Risk Conditions
11:55 AM - 12:20 PM EDT
Monday, March 22, 2021Room: V200 Ronney Laws Speaker
Maria Rescigno, PhD
Humanitas University
[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
Lipid Dysregulation in Inflammation, NASH, and Cancer
12:20 PM - 12:45 PM EDT
Monday, March 22, 2021Room: V200 Ronney Laws Speaker
Daniel Heller, PhD
Memorial Sloan Kettering Cancer Center
[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
Short Talk: The α1-Na/K-ATPase/Src-p/PI3K Pathway Modulates the Survivin-SMAC Apoptotic “Switch” in NASH Related Hepatocellular Carcinoma: A Translational Study
12:45 PM - 1:00 PM EDT
Monday, March 22, 2021Room: V200 Ronney Laws Speaker
Juan Sanabria, MD
Marshall University/Case Western Reserve University
[Joint Session] Non-Alcoholic Fatty Liver Disease, Liver Inflammation and Fibrogenesis in the Pathogenesis of Hepatobiliary Cancers
[Joint Session] Career Roundtable
2:30 PM - 3:30 PM EDT
Monday, March 22, 2021Panelists
Kendra Bence, PhD
Pfizer Inc.
Augusto Villanueva Rodriguez, MD, PhD
Icahn School of Medicine at Mount Sinai
Xin Wei Wang, PhD
NCI, National Institutes of Health
Career Roundtable
Genetics of NAFLD
5:00 PM - 7:10 PM EDT
Monday, March 22, 2021Room: Multi Tech Session Co-Chairs
Jay Horton, MD
University of Texas Southwestern Medical Center
Henry Ginsberg, MD
Columbia University Vagelos College of Physicians and Surgeons
Genetics of NAFLD
Use of GWAS to Identify SNPs Associated with NAFLD
5:00 PM - 5:25 PM EDT
Monday, March 22, 2021Room: V100 Atticus Kiser Speaker
Elizabeth Speliotes, MD, PhD
University of Michigan
Genetics of NAFLD
Genomics and Liver Disease in Diverse Populations: From Biobanks to Patients
5:25 PM - 5:50 PM EDT
Monday, March 22, 2021Room: V100 Atticus Kiser Speaker
Noura Abul-Husn, MD, PhD
Icahn School of Medicine at Mount Sinai
Genetics of NAFLD
Short Talk: Mouse and Human Population Studies Revealed Sex-Specific Roles of Liver Pyruvate Kinase in Promoting NAFLD/NASH
5:50 PM - 6:05 PM EDT
Monday, March 22, 2021Room: V100 Atticus Kiser Speaker
Karthickeyan Chella Krishnan, PhD
University of Cincinnati
Genetics of NAFLD
Short Talk: Human Hepatocyte PNPLA3 148M Exacerbates Rapid Non-Alcoholic Fatty Liver Disease Development in Chimeric Mice
6:05 PM - 6:20 PM EDT
Monday, March 22, 2021Room: V100 Atticus Kiser Speaker
Mohammad Kabbani, MD
Rockefeller University
Genetics of NAFLD
Coffee Break
6:20 PM - 6:40 PM EDT
Monday, March 22, 2021Genetics of NAFLD
Short Talk: Hepatocyte-Specific Deletion of ROCK1 Prevents Liver Inflammation and Fibrosis in Murine Nonalcoholic Steatohepatitis
6:40 PM - 6:55 PM EDT
Monday, March 22, 2021Room: V600 Zach Smith Speaker
Ester Dohnalkova, PharmD
Mayo Clinic
Genetics of NAFLD
Short Talk: Acetyl-CoA Metabolism Drives Epigenome Change in Steatosis Leading to Widespread Abnormal Transcription and DNA Damage
6:55 PM - 7:10 PM EDT
Monday, March 22, 2021Room: V600 Zach Smith Speaker
Neil Youngson, BS
Institute of Hepatology
Genetics of NAFLD
NAFLD and CVD
7:10 PM - 8:00 PM EDT
Monday, March 22, 2021Room: Multi Tech Session Co-Chairs
Henry Ginsberg, MD
Columbia University Vagelos College of Physicians and Surgeons
Jay Horton, MD
University of Texas Southwestern Medical Center
NAFLD and CVD
The AAA Atpase Torsin A, a New, Potent Player in VLDL Secretion, NAFL, and NASH
7:10 PM - 7:35 PM EDT
Monday, March 22, 2021Room: V500 Travis Lodolinski Speaker
Henry Ginsberg, MD
Columbia University Vagelos College of Physicians and Surgeons
NAFLD and CVD
Molecular Mediators of NAFLD and Hyperlipidemia
7:35 PM - 8:00 PM EDT
Monday, March 22, 2021Room: V500 Travis Lodolinski Speaker
Jay Horton, MD
University of Texas Southwestern Medical Center
NAFLD and CVD
Tuesday, March 23, 2021
Role of Lipids in NAFLD
10:00 AM - 1:00 PM EDT
Tuesday, March 23, 2021Room: Multi Tech Session Co-Chairs
Catherine Postic, PhD
INSERM Institut Cochin
Hannele Yki-Järvinen, MD, PhD
University of Helsinki
Role of Lipids in NAFLD
Circadian Contributions to NAFLD
10:00 AM - 10:25 AM EDT
Tuesday, March 23, 2021Room: V500 Travis Lodolinski Speaker
Mitchell Lazar, MD, PhD
Perelman School of Medicine, University of Pennsylvania
Role of Lipids in NAFLD
Altered Insulin Signaling and Glucose Toxicity in NAFLD
10:25 AM - 10:50 AM EDT
Tuesday, March 23, 2021Room: V500 Travis Lodolinski Speaker
Catherine Postic, PhD
INSERM Institut Cochin
Role of Lipids in NAFLD
Effects of Genetic Risk Factors for NAFLD on Hepatic Lipid Metabolism
10:50 AM - 11:15 AM EDT
Tuesday, March 23, 2021Room: V500 Travis Lodolinski Speaker
Hannele Yki-Järvinen, MD, PhD
University of Helsinki
Role of Lipids in NAFLD
Coffee Break
11:15 AM - 11:35 AM EDT
Tuesday, March 23, 2021Role of Lipids in NAFLD
Host Microbiome Interactions in Health and Disease
11:35 AM - 12:00 PM EDT
Tuesday, March 23, 2021Room: V200 Ronney Laws Speaker
Eran Elinav, MD, PhD
Weizmann Institute of Science
Role of Lipids in NAFLD
Short Talk: Lack of VMP1 Impairs Hepatic Lipoprotein Secretion and Promotes Nonalcoholic Steatohepatitis in Mice
12:00 PM - 12:15 PM EDT
Tuesday, March 23, 2021Room: V200 Ronney Laws Speaker
HongMin Ni, MD
University of Kansas Medical Center
Role of Lipids in NAFLD
Short Talk: Sexually Dimorphic Mechanisms of Action of TTC39B in Hepatic Lipogenic Gene Expression
12:15 PM - 12:30 PM EDT
Tuesday, March 23, 2021Room: V200 Ronney Laws Speaker
Joanne Hsieh, PhD
Columbia University
Role of Lipids in NAFLD
Short Talk: An ER Lipid Scramblase (ELS) Safeguards Lipoprotein Biogenesis and Lipid Homeostasis
12:30 PM - 12:45 PM EDT
Tuesday, March 23, 2021Room: V200 Ronney Laws Speaker
Xiao-Wei Chen, PhD
Peking University
Role of Lipids in NAFLD
Short Talk: Serine Catabolism Generates NADPH to Support Hepatic Lipogenesis
12:45 PM - 1:00 PM EDT
Tuesday, March 23, 2021Room: V200 Ronney Laws Speaker
Zhaoyue Zhang, MS
Princeton University
Role of Lipids in NAFLD
[Joint Session] Meet the Editors Roundtable
2:30 PM - 3:30 PM EDT
Tuesday, March 23, 2021Panelists
Elena Bellafante
Med- Cell Press
Francesco Giovinazzo
Frontiers
Xin (Cindy) Sun, PhD
Journal of Experimental Medicine (JEM)
Meet the Editors Roundtable
Pathways to NASH
5:00 PM - 7:45 PM EDT
Tuesday, March 23, 2021Room: Multi Tech Session Co-Chairs
Morris Birnbaum, MD, PhD
Pfizer Inc.
Tobias Walther, PhD
Harvard School of Public Health
Pathways to NASH
Lipid Droplet Formation and Lipophagy in Fatty Liver Disease
5:00 PM - 5:25 PM EDT
Tuesday, March 23, 2021Room: V400 Ryan Reid Speaker
Mark McNiven, PhD
Mayo Clinic
Pathways to NASH
Lipid Droplet Biology in NAFLD
5:25 PM - 5:50 PM EDT
Tuesday, March 23, 2021Room: V400 Ryan Reid Speaker
Tobias Walther, PhD
Harvard School of Public Health
Pathways to NASH
Short Talk: Ceramides as Mediators of Endoplasmic Reticulum Stress in NASH
5:50 PM - 6:05 PM EDT
Tuesday, March 23, 2021Room: V400 Ryan Reid Speaker
Annelise Poss, BS
University of Utah
Pathways to NASH
Coffee Break
6:05 PM - 6:30 PM EDT
Tuesday, March 23, 2021Pathways to NASH
Short Talk: The Small Intestine Shields the Liver from Fructose-Induced Steatosis
6:30 PM - 6:45 PM EDT
Tuesday, March 23, 2021Room: V200 Ronney Laws Speaker
Cholsoon Jang, PhD
University of California, Irvine
Pathways to NASH
Short Talk: Activation of Hepatic mTORC1 Protects Against NASH via Dual Regulation of VLDL- TAG Secretion and De Novo Lipogenesis
6:45 PM - 7:00 PM EDT
Tuesday, March 23, 2021Room: V200 Ronney Laws Speaker
Kahealani Uehara, BS
University of Pennsylvania
Pathways to NASH
Short Talk: The Hepatic Crown-like Structure in NASH: A Nexus between Monocyte-Derived Macrophages, Hepatic Stellate Cells, and Tissue Fibrosis
7:00 PM - 7:15 PM EDT
Tuesday, March 23, 2021Room: V200 Ronney Laws Speaker
Sabine Daemen, PhD
Washington University in St. Louis
Pathways to NASH
Short Talk: Lipid-Induced Endothelial Vascular Cell Adhesion Molecule 1 Promotes Nonalcoholic Steatohepatitis Pathogenesis
7:15 PM - 7:30 PM EDT
Tuesday, March 23, 2021Room: V200 Ronney Laws Speaker
Samar Ibrahim, MB, CHB
Mayo Clinic
Pathways to NASH
Short Talk: Immunity-Related GTPase IFGGA2 Induces Degradation of Hepatic Lipids by Lipophagy
7:30 PM - 7:45 PM EDT
Tuesday, March 23, 2021Room: V200 Ronney Laws Speaker
Wenke Jonas, PhD
German Institute of Human Nutrition
Pathways to NASH
Wednesday, March 24, 2021
Emerging Therapies for NASH
10:00 AM - 1:25 PM EDT
Wednesday, March 24, 2021Room: Multi Tech Session Co-Chairs
Hannele Yki-Järvinen, MD, PhD
University of Helsinki
Morris Birnbaum, MD, PhD
Pfizer Inc.
Emerging Therapies for NASH
DGAT2 Inhibition for NASH
10:00 AM - 10:25 AM EDT
Wednesday, March 24, 2021Room: V400 Ryan Reid Speaker
Morris Birnbaum, MD, PhD
Pfizer Inc.
Emerging Therapies for NASH
Combination Therapies for NASH Cirrhosis
10:25 AM - 10:50 AM EDT
Wednesday, March 24, 2021Room: V400 Ryan Reid Speaker
Chuhan Chung, MD
Gilead Sciences
Emerging Therapies for NASH
[NOT AVAILABLE ON DEMAND] Role of ATP Citrate Lyase (ACLY) in NASH and HCC
10:50 AM - 11:15 AM EDT
Wednesday, March 24, 2021Room: V400 Ryan Reid Speaker
Greg Steinberg, PhD
McMaster University
Emerging Therapies for NASH
Inhibition of Fructose Metabolism for the Treatment of NAFLD
11:15 AM - 11:40 AM EDT
Wednesday, March 24, 2021Room: V400 Ryan Reid Speaker
Kendra Bence, PhD
Pfizer Inc.
Emerging Therapies for NASH
Coffee Break
11:40 AM - 11:50 AM EDT
Wednesday, March 24, 2021Emerging Therapies for NASH
Therapeutic FGF19 in Non-Alcoholic Steatohepatitis
11:50 AM - 12:15 PM EDT
Wednesday, March 24, 2021Room: V200 Ronney Laws Speaker
Lei Ling, PhD
NGM Biopharmaceuticals
Emerging Therapies for NASH
Short Talk: A Drug-Like Sphingolipid Opposes Mitochondrial Fragmentation and Corrects the Metabolic Sequelae of Obesity
12:15 PM - 12:30 PM EDT
Wednesday, March 24, 2021Room: V200 Ronney Laws Speaker
Aimee Edinger, PhD
University of California, Irvine
Emerging Therapies for NASH
Short Talk: Inhibition of Hepatocyte Inflammasome Improves Features of NASH in foz/foz Mice
12:30 PM - 12:45 PM EDT
Wednesday, March 24, 2021Room: V200 Ronney Laws Speaker
Brian Rady
Janssen R&D
Emerging Therapies for NASH
Short Talk: Development of Liver-Targeted Interleukin-22 for Fatty Liver Disease
12:45 PM - 1:00 PM EDT
Wednesday, March 24, 2021Room: V200 Ronney Laws Speaker
Haressh Sajiir
University of Queensland - Mater Research Institute
Emerging Therapies for NASH
Short Talk: HHcy is a Feature and Mediator of NASH that Permits B12 and Folate to be an Effective Therapy for NASH
1:00 PM - 1:15 PM EDT
Wednesday, March 24, 2021Room: V200 Ronney Laws Speaker
Madhulika Tripathi, PhD
Duke-NUS Medical School Singapore
Emerging Therapies for NASH
Closing Remarks
1:15 PM - 1:25 PM EDT
Wednesday, March 24, 2021Room: V200 Ronney Laws Emerging Therapies for NASH
